Gilead’s Veklury should be effective against COVID-19 variants
Company has completed genetic analysis for UK and South African variants
Read More
Tag: remdesivir
Gilead’s COVID-19 drug remdesivir bags US approval
Antiviral becomes first COVID-19 treatment approved in the US
Read More
Systematic benefit-risk study deems remdesivir a ‘favourable’ COVID-19 treatment
Study recorded all possible benefits and risks for COVID-19 patients receiving treatment
Read More
Gilead aims for approval of COVID-19 drug remdesivir in the US
Drug has already been approved in the EU and Japan
Read More
Pfizer inks manufacturing deal with Gilead for COVID-19 med remdesivir
Pfizer becomes one of multiple external manufacturing organisations supporting scale-up of treatment
Read More
Gilead begins PhI trial of inhaled remdesivir
The inhaled formulation is being assessed for COVID-19 patients in the outpatient setting
Read More
Eight medicines leap towards EU approval
The recommendations include a conditional approval for Gilead’s Veklury (remdesivir) for COVID-19
Read More
CHMP backs approval of remdesivir as COVID-19 treatment
The drug is the first to be recommended as a treatment for the virus in the EU
Read More
Gilead to start testing an inhaled form of remdesivir
The firm is targeting an earlier stage in the treatment pathway for COVID-19
Read More
Remdesivir for COVID-19 patients is ‘favourable’, study finds
However, the amount of safety data available for the drug is still limited
Read More
Roche begins trial of Actemra/RoActemra plus remdesivir
The trial will test the potential of combining an antiviral with an immune modulator
Read More
NHS patients to be given experimental coronavirus therapy remdesivir
The drug will be provided to the NHS free of charge by Gilead via the UK’s early access to medicines scheme
Read More
- US study reveals interferon combinations cause lupus symptoms and affect treatment
- NIHR and TJBCM announce new funding initiative for novel brain tumour research
- UKHSA and ICL confirm variant which plays key role in global surge of Strep A infections
- Study reveals heart failure device could monitor patients and prevent hospitalisation
- MIT’s new MRI brain light-detecting technique could support brain cell studies
